S. T. F. M. Frequin - Concepedia

Author

S. T. F. M. Frequin

Also Known As

B. De Jong, Frequin, STFM, Jan Koeman, S T F M Frequin, S T Frequin, S. T. F. M. Frequin, S. T.F.M. Frequin, S.T.F. Frequin, S.T.F.M. Frequin, Stephan Frequin

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

St. Antonius Ziekenhuis Radboud University Nijmegen Jeroen Bosch Ziekenhuis Elisabeth-TweeSteden Ziekenhuis University of Amsterdam

About

S. T. F. M. Frequin is an author at St. Antonius Ziekenhuis specializing in multiple sclerosis, medicine, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	830
2	Health Sciences	2	2	406
3	Public Health	2	2	148
4	Education	1	1	11
5	Engineering	1	1	26

S. T. F. M. Frequin

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Correlating MRI and clinical disease activity in multiple sclerosis M.A.A. van Walderveen, Frederik Barkhof, O. R. Hommes, Neurology NeurorehabilitationSpinal Cord InjuryMs PatientsMedical ImagingNeurological Disorder	1995	294
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. Frederik Barkhof, Philip Scheltens, S. T. F. M. Frequin, American Journal of Roentgenology	1992	165
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis M.A.A. van Walderveen, M. W. Tas, Frederik Barkhof, Neurology Magnetic Resonance EvaluationMr Disease ActivityNeurological DisorderGynecologyMaternal Health	1994	121
A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone Frederik Barkhof, S. T. F. M. Frequin, O.R. Hommes, Neurology Neurological DisorderWhite MatterImmunologyMyelin BreakdownNeuroinflammation	1992	112
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial John Foley, Gilles Defer, Lana Zhovtis Ryerson, The Lancet Neurology Relapsing-remitting Multiple SclerosisClinical NeurologyClinical TrialsNeurological ProgressTreatment Option	2022	103
MRI pattern in asymptomatic natalizumab-associated PML Mike P. Wattjes, Anke Vennegoor, Martijn D. Steenwijk, Journal of Neurology Neurosurgery & Psychiatry	2014	90
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis Frederik Barkhof, M. W. Tas, S. T. F. M. Frequin, Neuroradiology Neurological DisorderResonanceClinical NeurologyNeurological ProgressNeuroimaging	1994	57
CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone S. T. F. M. Frequin, Frederik Barkhof, K.J.B. Lamers, Acta Neurologica Scandinavica	1992	47
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS Mike P. Wattjes, Martijn T. Wijburg, Jeroen van Eijk, Journal of Neurology Neurosurgery & Psychiatry	2017	43
Daily negative interactions and mood among patients and partners dealing with multiple sclerosis (MS): The moderating effects of emotional support Annet Kleiboer, Roeline G. Kuijer, Joop J. Hox, Social Science & Medicine PsychiatryEmotion RegulationMood SymptomPsychosocial ResearchAffective Neuroscience	2006	34

Page 1